Increase/Decrease in Cash: The total change in cash for the company over the given period.
Mesoblast Limited (MESO) had Increase/Decrease in Cash of $-24.93M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$69.68M |
|
$1.00M |
|
$583.64M |
|
$653.32M |
|
$72.75M |
|
$101.47M |
|
$119.31M |
|
$192.06M |
|
$461.26M |
|
$-113.62M |
|
$461.26M |
|
115.24M |
|
| Cash Flow Statement Financials | |
$-20.66M |
|
$0.63M |
|
$-4.26M |
|
$62.96M |
|
$38.03M |
|
|
Increase/Decrease in Cash |
$-24.93M |
$15.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|